Company intelligence / Profile preview

CellBank of Japan

Chuo-ku, Tokyo, Japan

Ownership: Private
Development stage: Other

Overview

CellBank is a Japanese biotechnology company specializing in the storage and processing of human cells for regenerative medicine and cosmetic applications. The company operates a large-scale Cell Processing Center (CPC) and provides autologous cell culture services, particularly focusing on skin fibroblast and stem cell therapies. CellBank supports medical institutions by offering cell banking infrastructure and technical expertise to facilitate advanced medical treatments. Their business model encompasses both direct therapeutic services and the provision of specialized equipment and consulting for cell processing facilities.

Therapeutic areas: NeurologyRheumatologyDermatology
Modalities: Cell therapyStem cell therapyAutologous cell therapy
Industry: Biotech

Beyond the preview

Go deeper on CellBank of Japan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CellBank of Japan.

Explore the full profile